Main menu

One solution — from R&D, to QC

Identity, integrity, and hidden risks, all in one view.

Cell and gene therapy development presents significant complexity. Next-generation sequencing (NGS) is essential as a critical quality control (QC) checkpoint throughout development — helping ensure product consistency, efficacy, and safety.


Brochure: biopharma CGT — 2 pages

Cell and gene guide

Learn how our sequencing technology delivers ultra-rich, multiomic data for comprehensive insights. Resolve complex questions fast with simple solutions driven by data.


Don't take our word for it

Application of nanopore long-read sequencing to sterility testing for cell therapy products

Breaking barriers in cell & gene therapy

Recent publications


Accuracy you can trust — insights you can act on

Long reads spanning entire plasmids and AAV genomes reveal structure, orientation, and sequence continuity — helping teams understand not only what’s present, but how it may behave within complex therapeutic systems.


入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag